STXI

Strive International Developed Markets ETF

Fund Objective 

STXI seeks to track the total return performance, before fees and expenses, of an index composed of developed markets, ex-US securities.

Fund Description 

STXI is a passively managed exchange-traded fund (ETF) that seeks to provide diversified exposure to international large- and mid-cap developed markets, excluding US securities. Through Corporate Governance practices, including voting proxy shares and proactively engaging with management teams and boards, Strive aims to unlock value across all corporations in STXI’s portfolio by mandating companies to focus on excellence.

Fund Data & Pricing
Net Assets as of 11/24/2025 $20.84m
NAV $29.78
Shares Outstanding 700,000
Premium/discount Percentage 0.23%
Closing Price $29.85
Median 30 Day Spread 0.23%

Data as of 11/24/2025

IOPV, or Indicative Optimized Portfolio Value, is a calculation disseminated by the stock exchange that approximates the Fund's NAV every fifteen seconds throughout the trading day.

Median 30 Day Spread is a calculation of Fund's median bid-ask spread, expressed as a percentage rounded to the nearest hundredth, computed by: identifying the Fund's national best bid and national best offer as of the end of each 10 second interval during each trading day of the last 30 calendar days; dividing the difference between each such bid and offer by the midpoint of the national best bid and national best offer; and identifying the median of those values.

The Fund expects to declare and to distribute its net investment income, if any, to shareholders as dividends on a monthly basis. The amount of any distribution will vary, and there is no guarantee a Fund will pay either an income dividend or a capital gains distribution.

Fund Information
Inception Date 06/25/2024
Primary Exchange NYSE
Ticker STXI
CUSIP 02072L524
Expense Ratio 0.29%
SEC 30-Day Yield 2.29%

* As of 10/31/2025

30 Day SEC Yield The yield is calculated with a standardized formula and represents net investment income earned by a fund over a 30-day period, expressed as an annual percentage rate based on the fund's share price. The yield includes the effect of any fee waivers and/or reimbursements. Without waivers, yields would be reduced. This is also referred to as the "standardized yield", “30-Day Yield” and “Current Yield”.

 

Performance Quarter end returns as of 09/30/2025
  Avg. Annualized
Quarter 1 Year 3 Year Since Inception
NAV 4.99% 15.77% 17.33%
Market Price 5.18% 14.06% 17.53%
Benchmark Index* 5.41% 16.45% 19.08%

Expense ratio: 0.29%

Inception Date: 06/25/2024

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 855-427-7360. Short term performance, in particular, is not a good indication of the fund's future performance, and an investment should not be made based solely on returns.

Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.

NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.

Distribution Detail
EX- Date Record Date Income Payable Date
09/29/2025 09/29/2025 0.12437616 09/30/2025
06/27/2025 06/27/2025 0.35558919 06/30/2025
4/14/2025 4/14/2025 0.09396951 4/17/2025
12/30/2024 12/30/2024 0.09615077 12/31/2024
9/27/2024 9/27/2024 0.06950682 9/30/2024
TOP 10 HOLDINGS
% Of Net Assets Name Ticker CUSIP Shares Held Market Value
2.29% ASML Holding NV ASML NA B929F46 483 477,974.26
1.67% AstraZeneca PLC AZN LN 0989529 1,902 347,432.10
1.66% Roche Holding AG ROG SW 7110388 897 345,017.07
1.52% Novartis AG NOVN SW 7103065 2,487 316,913.27
1.51% Nestle SA NESN SW 7123870 3,166 315,464.11
1.51% SAP SE SAP GR 4846288 1,314 314,180.20
1.46% HSBC Holdings PLC HSBA LN 0540528 22,215 305,204.70
1.31% Shell PLC SHEL LN BP6MXD8 7,506 272,762.97
1.29% Royal Bank of Canada RY CN 2754383 1,792 268,469.79
1.25% Siemens AG SIE GR 5727973 1,014 260,560.25

Data as of 11/25/2025. Holdings are subject to change.